Effects of Magnesium Content in the Feed on Cataract Development in Shumiya Cataract Rat

Journal of Oleo Science

Volumn 56, Issue 1, 2007, Pages 29-33

  Nagai, Noriaki ^a   Ito, Yoshimasa ^a   Tai, Hideyuki ^b   Hataguchi, Yoshihiro ^b   Nakagawa, Koji ^b  

^a KINKI UNIVERSITY   (Japan)

^b Ako Kasei Co Ltd   (Japan)

Author keywords

calcium; cataract; magnesium; Shumiya cataract rat

Indexed keywords

MAGNESIUM;

ANIMAL; ANIMAL FOOD; ARTICLE; CATARACT; COMPARATIVE STUDY; DIET; DRUG EFFECT; LENS; MAGNESIUM DEFICIENCY; METHODOLOGY; NEWBORN; PATHOLOGY; RAT; RAT STRAIN;

ANIMAL FEED; ANIMALS; ANIMALS, NEWBORN; CATARACT; DIET; LENS, CRYSTALLINE; MAGNESIUM; MAGNESIUM DEFICIENCY; RATS; RATS, MUTANT STRAINS;

EID: 34249035662     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.56.29     Document Type: Article

References (22)

1. Thylefors, B.; Negrel, A.D.; Pararajasegaram, R.; Dadzie, K.Y. Global data on blindness. Bull. World Health Organization. 73, 115-121 (1995).
2. Spector, A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 9, 1173-1182 (1995).
3. Shearer, T.R.; David, L.L.; Anderson, R.S.; Azuma, M. Review of selenite cataract. Curr. Eye Res. 11, 357-369 (1992).
4. Dilsiz, N.; Olcucu, A.; Atas, M. Determination of calcium, sodium, potassium and magnesium concentrations in human senile cataractous lenses. Cell Biochem. Funct. 18, 259-262 (2000).
5. Ornek, K.; Karel, F.; Buyukbingol, Z. May nitric oxide molecule have a role in the pathogenesis of human cataract? Exp. Eye Res. 76, 23-27 (2003).
6. Inomata, M.; Hayashi, M.; Shumiya, S.; Kawashima, S.; Ito,Y. Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR). Curr. Eye Res. 23, 307-311 (2001).
7. Ito, Y.; Nabekura, T.; Takeda, M.; Nakao, M.; Terao, M.; Hori, R.; Tomohiro, M. Curr. Eye Res. 22, 215-220 (2001).
8. Nabekura, T.; Koizumi, Y.; Nakao, M.; Tomohiro, M.; Inomata, M.; Ito, Y. Delay of cataract development in hereditary cataract UPL rats by disulfiram and aminoguanidine. Exp. Eye Res. 76, 169-174 (2003).
9. Yokoyama, T.; Oono, H.; Miyamoto, A.; Ishiguro, S.; Nishio, A. Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. Life Sci. 72, 1247-1257 (2003).
10. Shumiya, S.; Nagase, S. Breeding of hereditary cataract rat. Proc. Jpn. Assoc. Animal Model for Human Diseases. 4, 30 (1988).
11. Shumiya, S. Establishment of the hereditary cataractrat strain (SCR) and genetic analysis, Lab. Anim. Sci. 45, 671-673 (1995).
12. Mizuno, A.; Shumiya, S.; Toshima, S.; Nakano, T. Alteration of lens disulfide bonds in newly developed hereditary cataract rat. Jpn. J. Ophthalmol. 36, 417-425 (1992).
13. Inomata, M.; Nomura, K.; Takehana, M.; Saido, T.C.; Kawashima, S.; Shumiya, S. Evidence for the involvement of calpain in cataractogenesis in Shumiya cataract rat (SCR). Biochim. Biophys. Acta. 1362, 11-23 (1997).
14. AMERICAN INSTITUTE OF NUTRITION, Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies. J. Nutr. 107, 1340-1348 (1977).
15. Ito, Y.; Cai, H.; Koizumi, Y.; Nakao, M.; Terao, M. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats. Curr. Eye Res. 18, 292-299 (1999).
16. Abraham, A.S.; Eylath, U.; Weinstein, M.; Czaczkes, E. Serum magnesium levels in patients with acute myocardial infarction. N. Engl. J. Med. 296, 862-863 (1977).
17. Dyckner, T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta. Med. Scand. 207, 59-66 (1980).
18. Shatock, M.J.; Hearse, D.J.; Fry, C.H. The ionic basis of the anti-ischemic and anti-arrhythmic properties of magnesium in the heart. J. Am. Coll. Nutr. 6, 27-33 (1987).
19. Paolisso, G.; Barbagallo, M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am. J. Hypertens. 10, 346-355 (1997).
20. Yang, C.Y. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke. 29, 411-414 (1998).
21. Kao, W.H.; Folsom, A.R.; Nieto, F.J.; Mo, J.P.; Watson, R.L.; Brancati, F.L. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 159, 2151-2159 (1999).
22. Parfitt, K.; Sweetman, S.C.; Blake, P.S.; Parsins, A.V. Gastro-intestinal drugs: magnesium oxide. Martindale, The complete drug reference. 32nd ed. Pharmaceutical Press. London. pp. 1198–1199 (1999).